Castlight Health Inc (NYSE:CSLT) Given Consensus Rating of “Hold” by Analysts

Share on StockTwits

Shares of Castlight Health Inc (NYSE:CSLT) have earned a consensus rating of “Hold” from the six ratings firms that are covering the firm, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 12-month price target among analysts that have covered the stock in the last year is $5.00.

Several research firms have recently commented on CSLT. TheStreet cut Castlight Health from a “c-” rating to a “d+” rating in a research note on Monday, August 19th. ValuEngine upgraded Castlight Health from a “sell” rating to a “hold” rating in a research note on Thursday, August 1st. Zacks Investment Research upgraded Castlight Health from a “sell” rating to a “hold” rating in a research note on Tuesday, October 1st. Finally, Cantor Fitzgerald cut Castlight Health from an “overweight” rating to a “neutral” rating in a research report on Tuesday, July 30th.

In other Castlight Health news, EVP Maeve O’meara sold 28,171 shares of the company’s stock in a transaction on Monday, August 19th. The stock was sold at an average price of $1.41, for a total value of $39,721.11. Following the sale, the executive vice president now owns 322,775 shares of the company’s stock, valued at $455,112.75. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Mangini Siobhan Nolan sold 21,617 shares of the company’s stock in a transaction on Monday, August 19th. The shares were sold at an average price of $1.41, for a total value of $30,479.97. Following the completion of the sale, the chief financial officer now directly owns 281,610 shares in the company, valued at approximately $397,070.10. The disclosure for this sale can be found here. Insiders sold 60,858 shares of company stock worth $86,311 in the last three months. 17.37% of the stock is owned by corporate insiders.

A number of institutional investors have recently bought and sold shares of CSLT. Marshall Wace LLP acquired a new stake in shares of Castlight Health during the first quarter valued at $1,124,000. Acadian Asset Management LLC lifted its position in Castlight Health by 119.0% during the second quarter. Acadian Asset Management LLC now owns 557,923 shares of the software maker’s stock worth $1,802,000 after buying an additional 303,138 shares during the period. Concourse Capital Management LLC purchased a new position in Castlight Health during the second quarter worth about $218,000. Edge Wealth Management LLC lifted its position in Castlight Health by 14.0% during the second quarter. Edge Wealth Management LLC now owns 138,625 shares of the software maker’s stock worth $448,000 after buying an additional 17,000 shares during the period. Finally, Connor Clark & Lunn Investment Management Ltd. lifted its position in Castlight Health by 48.2% during the second quarter. Connor Clark & Lunn Investment Management Ltd. now owns 123,575 shares of the software maker’s stock worth $399,000 after buying an additional 40,175 shares during the period. 56.00% of the stock is currently owned by institutional investors.

NYSE CSLT traded down $0.03 on Friday, reaching $1.47. The stock had a trading volume of 10,079 shares, compared to its average volume of 541,309. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.88 and a current ratio of 1.88. Castlight Health has a 12-month low of $1.21 and a 12-month high of $4.15. The business’s 50-day moving average price is $1.43 and its 200 day moving average price is $2.60. The stock has a market cap of $216.42 million, a P/E ratio of -9.19 and a beta of 1.54.

Castlight Health (NYSE:CSLT) last released its quarterly earnings results on Tuesday, July 30th. The software maker reported ($0.02) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.01) by ($0.01). Castlight Health had a negative return on equity of 9.28% and a negative net margin of 19.68%. The company had revenue of $35.90 million for the quarter, compared to analysts’ expectations of $36.95 million. During the same quarter last year, the company earned ($0.10) EPS. Castlight Health’s revenue for the quarter was down 5.0% compared to the same quarter last year. On average, sell-side analysts predict that Castlight Health will post -0.2 earnings per share for the current year.

Castlight Health Company Profile

Castlight Health, Inc provides a software-as-a-service platform used for health benefits navigation for employees in the United States. Its platform matches employees to the resources their employers make available to them; managing a condition; and assists them to manage their benefits. The company also offers implementation, user and customer support, and marketplace services.

Recommended Story: How Investors Can Profit from Options Trading

Receive News & Ratings for Castlight Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Castlight Health and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

John B. Green Sells 12,500 Shares of Dicerna Pharmaceuticals Inc  Stock
John B. Green Sells 12,500 Shares of Dicerna Pharmaceuticals Inc Stock
Mondi  Share Price Crosses Above Two Hundred Day Moving Average of $1,658.89
Mondi Share Price Crosses Above Two Hundred Day Moving Average of $1,658.89
Meritor Inc  SVP Sells $330,750.00 in Stock
Meritor Inc SVP Sells $330,750.00 in Stock
Wedbush Weighs in on L Brands Inc’s Q4 2021 Earnings
Wedbush Weighs in on L Brands Inc’s Q4 2021 Earnings
IOST  Tops 1-Day Trading Volume of $30.80 Million
IOST Tops 1-Day Trading Volume of $30.80 Million
Etherparty  Price Hits $0.0032 on Exchanges
Etherparty Price Hits $0.0032 on Exchanges


 
© 2006-2019 Zolmax.